Ozempic / GLP-1 MDL Status Update — May 2026
Current case criteria. The firm is reviewing GLP-1 claims for sudden vision loss diagnosed as NAION only. We are not reviewing stomach or bowel injury claims, and we are not reviewing claims involving compounded semaglutide or tirzepatide. Read the NAION criteria. Last updated: May 2026 — Siddons Law Firm tracks active MDLs each month. Updates…